Unternehmen Nextgen Biomed Ltd TEL AVIV STOCK EXCHANGE
Aktien
IL0010839301
Medizinische Versorgung
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 48 | 20.11.22 | |
Dalia Mulakandov
DFI | Director of Finance/CFO | 39 | 17.01.23 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08.08.00 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Grossman
BRD | Director/Board Member | 49 | 12.06.22 |
Yaacov Amidror
CHM | Chairman | 76 | 07.01.21 |
Alon Pinkas
BRD | Director/Board Member | 62 | 17.11.22 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08.08.00 |
Tom Shabat
BRD | Director/Board Member | 35 | 06.12.22 |
Ilana Eldan
BRD | Director/Board Member | 43 | 18.12.22 |
Jacob Kaul
BRD | Director/Board Member | 74 | 17.11.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 8 082 701 | 7 441 086 ( 92,06 %) | 0 | 92,06 % |
Unternehmenskontakt
Nextgen Biomed Ltd.
P. O. Box 4318
, Raanana
+
![Straße Nextgen Biomed Ltd](https://cdn.zonebourse.com/static/address/10619570.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+9.95% | 27.41 Mrd. | |
+21.48% | 2.36 Mrd. | |
+13.31% | 2.27 Mrd. | |
-48.88% | 2.2 Mrd. | |
-30.74% | 2.03 Mrd. | |
+21.11% | 1.84 Mrd. | |
-15.10% | 1.7 Mrd. | |
+6.58% | 1.34 Mrd. | |
+16.77% | 1.24 Mrd. |